Q1 2013
Released Apr 24, 2013, after the close
10-Q filed Apr 24, 2013, 24 days after period end · 0001477932-13-001980
Q1 2013 · 10-Q
Revenue—
Net Income-$1.35M-$1.35M N/M vs Q1 2012N/M vs Q4 2012
EPS Diluted-$0.30-$0.30 N/M vs Q1 2012no prior Q4 2012 on file
Operating Income-$1,352,147N/M
Operating Cash Flow-$119N/M
Free Cash Flowderived-$1,325—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Net Income | -$1.35M | -$61.23K |
| EPS Diluted | -$0.30 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR